DK1325739T3 - Liposomer, der indkapsler anti-cancerlægemidler og anvendelsen deraf i behandlingen af maligne tumorer - Google Patents
Liposomer, der indkapsler anti-cancerlægemidler og anvendelsen deraf i behandlingen af maligne tumorerInfo
- Publication number
- DK1325739T3 DK1325739T3 DK01972111T DK01972111T DK1325739T3 DK 1325739 T3 DK1325739 T3 DK 1325739T3 DK 01972111 T DK01972111 T DK 01972111T DK 01972111 T DK01972111 T DK 01972111T DK 1325739 T3 DK1325739 T3 DK 1325739T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- malignant tumors
- cancer drugs
- liposomes encapsulating
- encapsulating anti
- Prior art date
Links
- 201000011510 cancer Diseases 0.000 title abstract 3
- 239000002502 liposome Substances 0.000 title abstract 3
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 229940041181 antineoplastic drug Drugs 0.000 title 1
- 108010038807 Oligopeptides Proteins 0.000 abstract 2
- 102000015636 Oligopeptides Human genes 0.000 abstract 2
- 108010028921 Lipopeptides Proteins 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- ZADHKSJXSZBQFB-HHHXNRCGSA-N lipid fragment Chemical compound CC(C)CCCCCCCCCCCC[C@@H](C)CCCCCCCC(C)C ZADHKSJXSZBQFB-HHHXNRCGSA-N 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200002447A ES2186484B1 (es) | 2000-10-10 | 2000-10-10 | Liposomas encapsulando farmacos anticancerosos y uso de los mismos en el tratamiento de tumores malignos. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1325739T3 true DK1325739T3 (da) | 2006-07-10 |
Family
ID=8495226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01972111T DK1325739T3 (da) | 2000-10-10 | 2001-10-03 | Liposomer, der indkapsler anti-cancerlægemidler og anvendelsen deraf i behandlingen af maligne tumorer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7153490B2 (es) |
| EP (1) | EP1325739B1 (es) |
| JP (1) | JP4286535B2 (es) |
| AT (1) | ATE318582T1 (es) |
| AU (1) | AU9190401A (es) |
| BR (1) | BR0113552A (es) |
| CA (1) | CA2425271C (es) |
| DE (1) | DE60117583T2 (es) |
| DK (1) | DK1325739T3 (es) |
| ES (2) | ES2186484B1 (es) |
| MX (1) | MXPA03003125A (es) |
| PT (1) | PT1325739E (es) |
| WO (1) | WO2002030397A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7968569B2 (en) * | 2002-05-17 | 2011-06-28 | Celgene Corporation | Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| EP1602659A1 (en) * | 2003-03-04 | 2005-12-07 | Sosei Co., Ltd. | Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| JPWO2005021012A1 (ja) * | 2003-08-29 | 2006-10-26 | テルモ株式会社 | ゲムシタビン封入薬剤担体 |
| EP1708752B1 (en) * | 2004-01-27 | 2012-02-22 | University Of Southern California | Polymer-bound antibody cancer therapeutic agent |
| ES2388064T3 (es) | 2004-04-22 | 2012-10-08 | Celator Pharmaceuticals, Inc. | Formulaciones liposomales de agentes de antraciclina y análogos de citidina |
| ES2293753B1 (es) * | 2004-04-28 | 2009-03-16 | Lipotec, S.A. | Uso de peptidos xikvav en preparacion de composiciones cosmeticas para mejorar la firmeza de la piel mediante el aumento de la adhesion celular. |
| CN100438855C (zh) * | 2006-01-19 | 2008-12-03 | 浙江大学 | 重酒石酸长春瑞滨脂质体及其冻干粉针与制备方法 |
| CN101209243B (zh) * | 2006-12-29 | 2010-12-08 | 石药集团中奇制药技术（石家庄）有限公司 | 一种脂质体药物及其制备方法 |
| JP4966084B2 (ja) | 2007-04-25 | 2012-07-04 | エスアイアイ・プリンテック株式会社 | インクジェットヘッドの駆動方法、インクジェットヘッドおよびインクジェット記録装置 |
| US8067432B2 (en) * | 2008-03-31 | 2011-11-29 | University Of Kentucky Research Foundation | Liposomal, ring-opened camptothecins with prolonged, site-specific delivery of active drug to solid tumors |
| WO2010135714A2 (en) | 2009-05-22 | 2010-11-25 | The Methodist Hospital Research Institute | Methods for modulating adipocyte expression using microrna compositions |
| CN103083239B (zh) | 2012-12-26 | 2015-11-25 | 中国人民解放军第四军医大学 | 一种蟾毒灵脂质体及其制备方法和应用 |
| US9895313B2 (en) | 2015-03-03 | 2018-02-20 | Cureport, Inc. | Combination liposomal pharmaceutical formulations |
| CN107530291A (zh) | 2015-03-03 | 2018-01-02 | 奎尔波特股份有限公司 | 双重负载的脂质体药物制剂 |
| CN106955271A (zh) * | 2016-01-08 | 2017-07-18 | 佛山英特医药科技有限公司 | 奥沙利铂聚集体及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985000968A1 (en) | 1983-09-06 | 1985-03-14 | Health Research, Inc. | Liposome delivery method for decreasing the toxicity of an antitumor drug |
| EP0211042A1 (en) * | 1985-01-18 | 1987-02-25 | Cooper-Lipotech, Inc. | Liposome composition and method |
| US4797285A (en) | 1985-12-06 | 1989-01-10 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Lipsome/anthraquinone drug composition and method |
| AU8329391A (en) | 1990-08-08 | 1992-03-02 | Liposome Technology, Inc. | Stable doxorubicin/liposome composition |
| ES2072223B1 (es) | 1993-11-25 | 1996-03-16 | Lipotec Sa | Liposomas encapsulando doxorubicina. |
| US6071532A (en) * | 1996-10-15 | 2000-06-06 | Emory University | Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof |
-
2000
- 2000-10-10 ES ES200002447A patent/ES2186484B1/es not_active Expired - Fee Related
-
2001
- 2001-10-03 DK DK01972111T patent/DK1325739T3/da active
- 2001-10-03 AU AU9190401A patent/AU9190401A/xx active Pending
- 2001-10-03 PT PT01972111T patent/PT1325739E/pt unknown
- 2001-10-03 EP EP01972111A patent/EP1325739B1/en not_active Expired - Lifetime
- 2001-10-03 US US10/398,627 patent/US7153490B2/en not_active Expired - Fee Related
- 2001-10-03 AT AT01972111T patent/ATE318582T1/de active
- 2001-10-03 BR BR0113552-0A patent/BR0113552A/pt not_active IP Right Cessation
- 2001-10-03 WO PCT/ES2001/000367 patent/WO2002030397A1/es active IP Right Grant
- 2001-10-03 ES ES01972111T patent/ES2259674T3/es not_active Expired - Lifetime
- 2001-10-03 JP JP2002533840A patent/JP4286535B2/ja not_active Expired - Fee Related
- 2001-10-03 DE DE60117583T patent/DE60117583T2/de not_active Expired - Lifetime
- 2001-10-03 MX MXPA03003125A patent/MXPA03003125A/es active IP Right Grant
- 2001-10-03 CA CA2425271A patent/CA2425271C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU9190401A (en) | 2002-04-22 |
| EP1325739B1 (en) | 2006-03-01 |
| ATE318582T1 (de) | 2006-03-15 |
| MXPA03003125A (es) | 2004-05-04 |
| EP1325739A1 (en) | 2003-07-09 |
| JP2004510811A (ja) | 2004-04-08 |
| CA2425271C (en) | 2011-04-19 |
| ES2186484B1 (es) | 2004-07-01 |
| BR0113552A (pt) | 2003-07-29 |
| DE60117583T2 (de) | 2006-10-05 |
| US7153490B2 (en) | 2006-12-26 |
| JP4286535B2 (ja) | 2009-07-01 |
| DE60117583D1 (de) | 2006-04-27 |
| WO2002030397A1 (es) | 2002-04-18 |
| AU2001291904B2 (en) | 2006-05-11 |
| CA2425271A1 (en) | 2003-04-08 |
| WO2002030397A9 (es) | 2004-05-13 |
| PT1325739E (pt) | 2006-07-31 |
| US20050100590A1 (en) | 2005-05-12 |
| ES2186484A1 (es) | 2003-05-01 |
| ES2259674T3 (es) | 2006-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1325739T3 (da) | Liposomer, der indkapsler anti-cancerlægemidler og anvendelsen deraf i behandlingen af maligne tumorer | |
| CY1112361T1 (el) | Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743 | |
| DK1296647T3 (da) | Polymermicellepræparater | |
| TR200002299T2 (tr) | Epotilon kompozisyonları. | |
| ES2249888T3 (es) | Conjugados de paclitaxel solubles en agua, combinados con irradiacion para el tratamiento del cancer. | |
| BRPI0518250A2 (pt) | tratamentos anticÂncer | |
| ATE104152T1 (de) | Verringerung der nebeneffekte bei der krebstherapie. | |
| CR7575A (es) | Uso de docetaxel/doxorrubicina/ciclofosfamida en la terapia adyuvante de cancer de mama y ovario | |
| HK1068606A1 (en) | Novel aminobenzoephenones | |
| EA200300427A1 (ru) | Противоопухолевая терапия, включающая производные дистамицина | |
| ATE484290T1 (de) | Peptid mit antitumoraler wirkung | |
| ATE187890T1 (de) | Ligandgerichtete enzyme-prodrug therapie | |
| ATE442128T1 (de) | Kombinierte chemo-immunotherapie mit liposomalen arzneistoffen und cytokinen | |
| ES2164011B1 (es) | Uso combinado de la quimiocina ip-10 y la interleucina-12 en la preparacion de composiciones para el tratamiento de tumores malignos. | |
| EA200801670A1 (ru) | Комбинированная противораковая терапия с перфузией изолированного органа | |
| EP1384487A4 (en) | MEDICAMENTS CONTAINING A GENETICALLY MODIFIED ANTIBODY AGAINST GD3 GANGLIOSIDE | |
| NO20075508L (no) | Stannsoporfinpreparater og administrering | |
| AR109456A2 (es) | Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación | |
| TR200000728T2 (tr) | Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı. | |
| RU2003122771A (ru) | Способ химиотерапии злокачественных опухолей | |
| BR0307979A (pt) | Método e preparação farmacêutica para reduzir as toxicidades gastrointestinais induzidas por terapia citoablatica , e método para melhorar terapia citoablativa de câncer | |
| UA44635A (uk) | Спосіб імунотерапії раку молочної залози | |
| AR033579A1 (es) | Terapia antitumoral que comprende derivados de distamicina |